| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64850-910-01 | 64850-910 | HUMAN PRESCRIPTION DRUG | Isradipine | Isradipine | CAPSULE | ORAL | 20221228 | N/A | ANDA | ANDA077169 | Elite Laboratories, Inc. | ISRADIPINE | 2.5 mg/1 | 100 CAPSULE in 1 BOTTLE (64850-910-01) |
| 64850-910-05 | 64850-910 | HUMAN PRESCRIPTION DRUG | Isradipine | Isradipine | CAPSULE | ORAL | 20221228 | N/A | ANDA | ANDA077169 | Elite Laboratories, Inc. | ISRADIPINE | 2.5 mg/1 | 500 CAPSULE in 1 BOTTLE (64850-910-05) |
| 64850-911-01 | 64850-911 | HUMAN PRESCRIPTION DRUG | Isradipine | Isradipine | CAPSULE | ORAL | 20221228 | N/A | ANDA | ANDA077169 | Elite Laboratories, Inc. | ISRADIPINE | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (64850-911-01) |
| 64850-911-05 | 64850-911 | HUMAN PRESCRIPTION DRUG | Isradipine | Isradipine | CAPSULE | ORAL | 20221228 | N/A | ANDA | ANDA077169 | Elite Laboratories, Inc. | ISRADIPINE | 5 mg/1 | 500 CAPSULE in 1 BOTTLE (64850-911-05) |